GINZA NOA CLINIC
Tokyo, Japan International Patient Support
Contact Us

Are Guaranteed Stem Cell Results Credible?

No. A clinic cannot credibly promise that a stem cell treatment will cure you, relieve your pain, or regrow tissue. A study can report how many people improved by a certain date; it cannot tell you with certainty what will happen to you. The U.S. Food and Drug Administration (FDA) warns that unapproved regenerative medicine products have been marketed as safe and effective without adequate evidence [1].

Before you pay a deposit, ask for the exact treatment name, what the clinic counts as success, and the human study behind the claim. This guide is general information, not personal medical advice.

Are Guaranteed Stem Cell Results Credible?

Find Out What Treatment Is Being Offered

  • Blood-forming stem cell transplant. This is an established treatment for certain blood cancers and other blood or immune disorders. The cells are given through a vein and can restore blood formation after intensive treatment. For cancer, eligibility depends on factors such as the type and stage of disease, prior treatment, donor availability, and whether the patient can tolerate the procedure [2].
  • An approved cell product for a specific condition. On December 18, 2024, the FDA approved Ryoncil (remestemcel-L-rknd), a donor bone marrow-derived mesenchymal stromal cell therapy, for children aged 2 months and older with acute graft-versus-host disease that does not respond to steroids. This disease can occur when donor immune cells attack the recipient’s tissues after a transplant. The approval does not cover knee pain, fatigue, or anti-aging [3].
  • An experimental treatment in a clinical trial. Ask for the trial identifier and the published results for your condition. A study listing lets you look up the research; it does not show that the treatment works or that the product is approved for marketing [1].
  • A privately offered infusion or injection. A clinic’s offer is not proof of approval or benefit. The FDA’s U.S. consumer warning covers unapproved products marketed for uses such as knee and back pain and names products derived from fat, cord tissue, or amniotic fluid, as well as exosomes [1].

What a Real Stem Cell Response Rate Measures

The FDA prescribing information for Ryoncil describes a multicenter study with 54 treated children who had steroid-refractory acute graft-versus-host disease after a donor blood stem cell transplant. The study had no comparison group. The planned initial course was eight intravenous infusions over four weeks, with additional infusions for some children depending on their response or recurrence [4]. The public trial record identifies the study as phase 3 and lists 55 enrolled patients; the FDA’s response figures use the 54 who received treatment [5] [4].

At day 28, 16 of 54 children (30%) had a complete response and 22 of 54 (41%) had a partial response. That leaves 16 of 54 who did not meet either definition at that assessment. The overall response rate was 38 of 54 (70% when calculated from the counts, not by adding the rounded percentages). A complete response meant the disease had resolved in all affected organs at that assessment, not that it could never return [4].

Among the 38 responders, the median response duration was 54 days, measured from the day-28 response until disease progression, new systemic treatment for the disease, or death. Without a comparison group, the study cannot tell you how much better the results were than with another option [4].

Common adverse reactions included infections, fever, bleeding, swelling, abdominal pain, and high blood pressure. The label also warns about serious allergic or infusion reactions, possible transmission of infections, and tissue growth in the wrong place. It calls for close monitoring and interruption of the infusion if a reaction occurs [4].

Does Registration or Filing Prove a Treatment Works?

Check the rules in the country where you would be treated. In Japan, Article 4 of the Act on the Safety of Regenerative Medicine requires hospitals and clinics covered by the Act to submit a provision plan before providing the service [6]. Filing that plan is not marketing approval for a product and does not establish that the service works. Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) publishes approval information for specific regenerative medical products [7].

For Japan-specific background, see how regenerative medicine provision plans are filed in Japan and what a cell processing center does.

How to check the evidence behind a clinic’s claim
What you’re shownWhat to check
A Japanese provision planMatch the plan to the clinic and the service offered. If the clinic claims product approval, ask for the exact product name and approved use, then check the PMDA record [6] [7].
A trial number or “FDA registered” claimLook up the study and check for results that match the offer. Neither a ClinicalTrials.gov listing nor a firm’s FDA registration establishes that the product is legally marketed [1].
A testimonial or success percentageAsk who was counted, how improvement was measured, how many people completed follow-up, and what happened in any comparison group. A testimonial cannot answer those questions.

How to Check a Clinic’s Claim in Practice

Suppose a clinic offers a knee injection and points to Ryoncil as proof that its treatment works. You can repeat the document check used for this guide: in the FDA label, compare “Indications and Usage” with “Clinical Studies.” The first section names the approved condition; the second explains what counted as a response. A day-28 response in children with a transplant complication is not a result for adults with knee pain [4].

Now ask the clinic for a study of the actual injection in people with your diagnosis. If it sends a patient testimonial instead, ask what else the patient received and whether the study had a comparison group. The improvement may be real without showing that the cells caused it; expectations alone can affect how someone feels [8].

Red Flags Before You Pay

  • “Risk-free because they’re your own cells.” Ask whether the clinic uses your own cells or donor cells, but do not take the cell source as proof of safety. The FDA has reported harms from unapproved regenerative products, including serious infections, blindness, tumor formation, neurological problems, unwanted immune reactions, and cells growing where they should not [1].
  • “Pay today to secure your result.” Ask for an itemized quote, follow-up charges, and written cancellation terms. This overview of stem cell treatment costs in Japan can help you identify charges to ask about. A refund policy is not evidence of a medical benefit.
  • No clear plan for complications. Ask who handles side effects after you leave, especially if you are traveling for care. Do not assume that risks from a transplant apply to a clinic injection: blood stem cell transplants have their own short- and long-term risks, including infection, organ damage, infertility, and, with donor cells, graft-versus-host disease [2].

Questions to Ask Before Agreeing to Treatment

  1. What exactly would I receive? Ask for the product name, cell type and source, dose, route, and planned number of sessions.
  2. Is this approved for my diagnosis where I’ll be treated, part of a clinical trial, or offered as a private service? Ask for the official record that matches the claim.
  3. What counted as success, how many patients met that definition out of everyone treated, and how long did the improvement last?
  4. What side effects were reported, who handles complications, and when would you reassess or stop treatment?

Take the written offer and the study to a clinician who is not selling the treatment. If you cannot verify that the evidence matches the product and your diagnosis, do not use the guarantee to decide whether to pay or change your care.

Questions about contacting the clinic in Japan?

Our patient support team handles general inquiries. For advice about a treatment offer, speak with your own doctor.

Contact patient support

An inquiry is not a medical consultation or a treatment recommendation.